CSIMarket
 
Lakeshore Biopharma Co Ltd  (NASDAQ: LSB)
 

Lakeshore Biopharma Co Ltd's Customers Performance

LSB



 
LSB's Source of Revenues During the corresponding time, Lakeshore Biopharma Co Ltd saw a revenue deteriorated by -19.18 % year on year, While revenue at the Lakeshore Biopharma Co Ltd's corporate clients

List of LSB Customers




for the same period Lakeshore Biopharma Co Ltd revnue deteriorated by -19.18 % year on year,

List of LSB Customers





Lakeshore Biopharma Co Ltd's Comment on Sales, Marketing and Customers



The company serves approximately 2,272 county-level CDC customer accounts in China. It plans to expand international operations through partnerships and licensing agreements with pharmaceutical companies to commercialize the YSJA TM rabies vaccine in select international markets, particularly Southeast Asia. Its product candidates, including the PIKA rabies vaccine, utilize proprietary PIKA immunomodulating technology aimed at viral infections and cancer. The PIKA rabies vaccine is designed to induce accelerated and strong cellular immunity with a shortened treatment regimen compared to existing vaccines.





Lakeshore Biopharma Co Ltd’s Comment on Sales, Marketing and Customers


The company serves approximately 2,272 county-level CDC customer accounts in China. It plans to expand international operations through partnerships and licensing agreements with pharmaceutical companies to commercialize the YSJA TM rabies vaccine in select international markets, particularly Southeast Asia. Its product candidates, including the PIKA rabies vaccine, utilize proprietary PIKA immunomodulating technology aimed at viral infections and cancer. The PIKA rabies vaccine is designed to induce accelerated and strong cellular immunity with a shortened treatment regimen compared to existing vaccines.








LSB's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Lakeshore Biopharma Co Ltd 67.04 80.82 -61.09 -
SUBTOTAL 0.00 0.00 0.00 -

Sources: Lakeshore Biopharma Co Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Lakeshore Biopharma Co Ltd’s corporate clients.
For your research, we’ve provided 9 tables on Lakeshore Biopharma Co Ltd corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.